RxSight

Summary

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

History

Founded in 2011, RxSight is a medical device and digital imaging company focused on providing innovative solutions to improve visual outcomes and quality of life for individuals living with vision-limiting eye conditions. We develop, market, and distribute a comprehensive suite of digital imaging products, and we are dedicated to improving and enhancing mission critical technologies for the visibility of retinal structures, helping physicians provide advanced levels of vision care.

Mission

RxSight strives to provide superior products and services to enable healthcare providers to improve patient care.

Vision

RxSight’s goal is to be a leader in retinal imaging, pioneering revolutionary products and applications that set the gold standard of care.

References

https://in.investing.com/equities/rxsight

https://finance.yahoo.com/quote/RXST/profile?p=RXST

https://www.crunchbase.com/organization/rxsight-inc

https://companiesmarketcap.com/

https://www.rxsight.com

Contacts

Follow Us

RxSight

Share

Contacts

Follow Us